Scynexis Inc
SCYXNasdaqCIK 1178253HealthcareFiscal year ends Dec 31
Reports and events: 174 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2816:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001178253-26-000037 |
| 2026-09-2208:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001178253-26-000035 |
| 2026-09-1008:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001178253-26-000031 |
| 2026-08-1016:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001178253-26-000027 |
| 2026-06-2616:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001178253-26-000021 |
| 2026-05-2916:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001178253-26-000017 |
| 2026-05-2216:20 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001178253-26-000014 |
| 2026-05-1116:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001178253-26-000011 |
| 2026-04-3016:29 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001140361-26-018207 |
| 2026-04-2716:18 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001140361-26-017112 |
| 2026-04-2016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001178253-26-000009 |
| 2026-03-3116:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-134476 |
| 2026-03-3107:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-133259 |
| 2026-03-3107:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-133250 |
| 2026-03-0416:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001178253-26-000007 |
| 2025-11-0516:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001178253-25-000010 |
| 2025-10-1508:00 ET | 8-K | 1.01 Entry into a material agreement | 0001178253-25-000006 |
| 2025-08-1316:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107985 |
| 2025-07-0116:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-092176 |
| 2025-06-2616:01 ET | 8-K | 3.01 Delisting notice | 0000950170-25-090374 |
| 2025-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072548 |
| 2025-04-3016:01 ET | DEF 14A | Proxy statementPeriod 2025-06-25 | 0001140361-25-016641 |
| 2025-03-1216:55 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038044 |
| 2024-11-0616:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-122291 |
| 2024-11-0616:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122241 |
| 2024-09-1008:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-104918 |
| 2024-08-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093856 |
| 2024-06-2008:07 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-075321 |
| 2024-05-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055590 |
| 2024-04-2516:33 ET | DEF 14A | Proxy statementPeriod 2024-06-19 | 0001140361-24-022086 |
| 2024-03-2816:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038046 |
| 2024-03-2816:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038015 |
| 2024-01-0509:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002308 |
| 2024-01-0216:01 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-24-000238 |
| 2023-11-1316:01 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062894 |
| 2023-10-0209:15 ET | 8-K | 8.01 Other events | 0000950170-23-050940 |
| 2023-09-2508:32 ET | 8-K | 8.01 Other events | 0000950170-23-049544 |
| 2023-08-1416:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042362 |
| 2023-06-2316:01 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0000950170-23-029599 |
| 2023-06-1616:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-028589 |
| 2023-05-1016:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-020486 |
| 2023-05-0116:05 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0001140361-23-022024 |
| 2023-03-3107:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-011138 |
| 2023-03-3007:08 ET | 8-K | 1.01 Entry into a material agreement | 0000950170-23-010748 |
| 2022-11-0916:03 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023822 |
| 2022-11-0907:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023510 |
| 2022-10-2017:21 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors | 0001564590-22-034777 |
| 2022-09-3016:01 ET | 8-K | 5.07 Shareholder vote results | 0001564590-22-032963 |
| 2022-08-1916:00 ET | DEF 14A | Proxy statementPeriod 2022-09-28 | 0001140361-22-030371 |
| 2022-08-1516:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-029486 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.